Clinical utility of ¹⁸ <scp>F</scp> ‐fluorocholine positron‐emission tomography/computed tomography ( <scp>PET</scp> / <scp>CT</scp> ) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study

Abstract

Our results support the usefulness of (18)F-fluorocholine PET/CT in biochemical relapse of prostate cancer after radical treatment, with an overall disease detection rate close to 50%, and it can be recommended as first-line treatment. As mentioned above, besides Trigger PSA levels, there are other clinical and pathological variables that need to be considered so as to screen patients properly and thus minimise the number of nodular lesions and increase the diagnostic accuracy of the examination.